WALVAX(SZ:300142) Xin Lang Cai Jing·2025-10-29 02:28Group 1 - Watson Bio (300142.SZ) reported its Q3 2025 results, with 12 institutional investors holding a total of 128 million A-shares, representing 8.00% of the total share capital [1] - The top ten institutional investors collectively hold 7.99% of the shares, with a decrease of 3.05 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, four funds increased their holdings, including Huaxia National Index Vaccine and Biotechnology Fund A, Guotai Chuangye Board Medical and Health ETF, and others, with a slight increase in holding ratio [2] - Six public funds reduced their holdings, with a total decrease ratio of 0.66%, including E Fund Chuangye Board ETF and others [2] - A total of 204 public funds did not disclose their holdings this period, including several notable funds in the innovative drug and biotechnology sectors [2]